Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups
(2019)
Journal Article
Byrne, J., Pearce, R., Perry, J., Crawley, C., & Jackson, G. (2019). Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups. Bone Marrow Transplantation, 54(7), 1151-1154. https://doi.org/10.1038/s41409-019-0439-y